Literature DB >> 9523989

Characterization of the phase transitions of trehalose dihydrate on heating and subsequent dehydration.

L S Taylor1, P York.   

Abstract

Many pharmaceutical compounds of interest form hydrates. The phase behavior of different particle size fractions of trehalose dihydrate was studied as the sugar was dehydrated by heating. Hot-stage microscopy, X-ray powder diffraction, thermogravimetric analysis, and differential scanning calorimetry were used to characterize the phase changes. Small particles (<45 microm) formed an amorphous phase on dehydration and subsequently liquefied at temperatures above the glass transition temperature of amorphous trehalose. Crystallization to the anhydrate was observed from this supercooled liquid. Large particles (>425 microm) underwent a solid-solid conversion from the dihydrate to the anhydrate at temperatures as low as 80 degrees C. This solid-solid conversion was explained by a catalytic effect of the liberated dihydrate water on the rearrangement of the dehydrated phase to the anhydrate. The large surface area-to-volume ratio of the small particles resulted in dehydration prior to attaining the threshold temperature for rearrangement, explaining why solid-solid conversion was absent for these particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523989     DOI: 10.1021/js970239m

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.

Authors:  Xiaojian Li; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2011-10-25       Impact factor: 3.246

2.  Structure in dehydrated trehalose dihydrate--evaluation of the concept of partial crystallinity.

Authors:  Meena Rani; Ramprakash Govindarajan; Rahul Surana; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

3.  Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.

Authors:  Jared R Snell; N S Krishna Kumar; Raj Suryanarayanan; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-05-13       Impact factor: 3.534

4.  Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.

Authors:  Madhav Vasanthavada; Wei-Qin Tong; Yatindra Joshi; M Serpil Kislalioglu
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate in situ FT-Raman spectroscopy.

Authors:  L S Taylor; A C Williams; P York
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

6.  Monitoring phase transformations in intact tablets of trehalose by FT-Raman spectroscopy.

Authors:  Paroma Chakravarty; Sunny P Bhardwaj; Leslie King; Raj Suryanarayanan
Journal:  AAPS PharmSciTech       Date:  2009-11-25       Impact factor: 3.246

7.  In vitro simulation of solid-solid dehydration, rehydration, and solidification of trehalose dihydrate using thermal and vibrational spectroscopic techniques.

Authors:  Shan-Yang Lin; Jui-Lung Chien
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

8.  Effect of preparation method on physical properties of amorphous trehalose.

Authors:  Rahul Surana; Abira Pyne; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

9.  Influence of Carbamazepine Dihydrate on the Preparation of Amorphous Solid Dispersions by Hot Melt Extrusion.

Authors:  Xiangyu Ma; Felix Müller; Siyuan Huang; Michael Lowinger; Xu Liu; Rebecca Schooler; Robert O Williams Iii
Journal:  Pharmaceutics       Date:  2020-04-20       Impact factor: 6.321

10.  Stable Dried Catalase Particles Prepared by Electrospraying.

Authors:  Corinna S Schlosser; Steve Brocchini; Gareth R Williams
Journal:  Nanomaterials (Basel)       Date:  2022-07-20       Impact factor: 5.719

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.